DGM

Darwin Global Management Portfolio holdings

AUM $2.38B
1-Year Est. Return 81.43%
This Quarter Est. Return
1 Year Est. Return
+81.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$859M
AUM Growth
+$108M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$246M
2
+$237M
3
+$106M
4
CRBP icon
Corbus Pharmaceuticals
CRBP
+$14.3M
5
RNA icon
Avidity Biosciences
RNA
+$8.11M

Top Sells

1
+$108M
2
+$80.8M
3
+$78.6M
4
BEAM icon
Beam Therapeutics
BEAM
+$70M
5
APGE icon
Apogee Therapeutics
APGE
+$55.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$246M 28.63%
+4,575,558
2
$237M 27.58%
+3,541,095
3
$164M 19.07%
2,080,946
-669,858
4
$106M 12.35%
+23,915,480
5
$68.8M 8%
1,525,902
+89,952
6
$14.3M 1.66%
+325,140
7
$10.3M 1.19%
452,040
-21,160
8
$8.11M 0.94%
+200,000
9
$4.81M 0.56%
1,916,290
-416,638
10
– –
-832,198
11
– –
-2,119,598
12
– –
-1,476,974
13
– –
-79,600
14
– –
-1,436,964
15
– –
-1,109,650
16
– –
-1,982,016
17
– –
-465,000